Analytical Data
-
Gene name
SNCaIP1
- Application
-
Alternative Names
SYPH1; Sph1; Synphilin 1; Alpha-synuclein-interacting protein
-
Species
Rat
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
D3ZWQ5
-
Expression Region
Pro766~Leu963
-
Molecular Weight
52kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SNCaIP1, or Synaptic Nerve Cell Protein 1, is an important protein involved in the regulation of synaptic function and neural plasticity, making it crucial for understanding various neurobiological processes and neurological disorders. Its role in the transport and modulation of synaptic vesicles highlights its potential links to neurodegenerative diseases such as Alzheimer's and Parkinson's, where synaptic dysfunction is a hallmark feature. The recombinant production of SNCaIP1 protein serves as a valuable tool for researchers, allowing for the investigation of its structural properties and biochemical interactions in vitro. By generating and characterizing this protein, studies can elucidate its role in synaptic transmission and identify possible therapeutic targets for enhancing synaptic health. Moreover, understanding the mechanisms of SNCaIP1 can provide insights into synaptic pathology, ultimately contributing to the development of novel strategies for treating cognitive impairments and other neurodegenerative conditions. The study of recombinant SNCaIP1 is thus a promising venture in the field of neuroscience, with the potential to pave the way for advancements in our understanding of brain function and dysfunction.
